Lactose (India) Limited share price
BSE: LACTOSE
Key numbers
- Market cap
- ₹ 142 Cr
- Current price
- ₹ 112.50
- 52-week high / low
- ₹ 136 / 76
- Stock P/E
- 20.8
- Book value
- ₹ 51.4
- Dividend yield
- 0.00%
- ROCE
- 11.1%
- ROE
- 9.8%
- Debt to equity
- 0.96
- Sales growth (3 yrs)
- 36.0%
- Profit growth (3 yrs)
- 71.1%
- 1-year return
- -13.0%
About Lactose (India) Limited
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; liquid dosage forms; and anhydrous and inhalation grade lactose. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic. In addition, the company exports its products. Lactose (India) Limited was incorporated in 1991 and is headquartered in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 40 | 41 | 37 | 46 | 47 |
| Operating profit | 4 | 5 | 3 | 5 | 6 |
| Net profit | 2 | 2 | 1 | 2 | 2 |
| EPS (₹) | 1.19 | 1.71 | 0.42 | 1.49 | 1.88 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.